Cargando…
Antibodies, Nanobodies, or Aptamers—Which Is Best for Deciphering the Proteomes of Non-Model Species?
This planet is home to countless species, some more well-known than the others. While we have developed many techniques to be able to interrogate some of the “omics”, proteomics is becoming recognized as a very important part of the puzzle, given how important the protein is as a functional part of...
Autores principales: | Dhar, Poshmaal, Samarasinghe, Rasika M., Shigdar, Sarah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7177290/ https://www.ncbi.nlm.nih.gov/pubmed/32260091 http://dx.doi.org/10.3390/ijms21072485 |
Ejemplares similares
-
Non-Invasive Delivery of Therapeutics into the Brain: The Potential of Aptamers for Targeted Delivery
por: Bukari, Bakhtiar, et al.
Publicado: (2020) -
Zebrafish Models of Paediatric Brain Tumours
por: Basheer, Faiza, et al.
Publicado: (2022) -
Unravelling the Glioblastoma Tumour Microenvironment: Can Aptamer Targeted Delivery Become Successful in Treating Brain Cancers?
por: Giles, Breanna, et al.
Publicado: (2023) -
Augmented reality in medical education: students’ experiences and learning outcomes
por: Dhar, Poshmaal, et al.
Publicado: (2021) -
Aptamer-Based Diagnostics and Therapeutics
por: Shigdar, Sarah
Publicado: (2019)